Parenteral Nutrition Market is estimated to be US$ 10.33 billion by 2030 with a CAGR of 5.8% during the forecast period

Download Sample

Published Date: July 2023

The Global Parenteral Nutrition Market accounted for US$ 5.90 billion in 2020 and is estimated to be US$ 10.33 million by 2030 and is anticipated to register a CAGR of 5.8%. Parenteral nutrition (PN) is the intravenous administration of nutrition, which can include protein, carbohydrate, fat, minerals and electrolytes, vitamins, and other trace elements, to patients who are unable to eat or absorb enough food through tube feeding formula or by mouth to maintain a healthy nutritional status. When the intestine is unable to absorb enough nutrients for your child to grow and develop appropriately, parenteral feeding is employed. A liquid solution containing nutrients for growth and development (vitamins, minerals, carbs, proteins, and lipids) is injected straight into a vein.

The report " Global Parenteral Nutrition Market, By Nutrition Type (Single Dose Amino Acid Solution, Carbohydrates, Parenteral Lipid Emulsion, Trace Elements, and Vitamins & Minerals) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast Till 2029’’

Key Highlights:

In September 2019, EFCNI proudly announces the launch of their position paper “Addressing the nutritional emergency of preterm birth – Optimal practice in neonatal parenteral nutrition”.
In August 2019, JW Life Science said that Baxter Pharmaceutical, its European partner, has launched Finomel, a ready-to-use triple-chamber bag for parenteral nutrition (PN), in EU. Finomel is a third-generation nutrient solution that ideally combines omega-3 and omega-6, which promote patient recovery, and vitamin E, thus improving immunity. The product also contains the highest omega-3 content among the three-chamber PN products currently sold in the market.

Analyst View:

Due to insufficient nutrition for newborns, which results in reduced cognitive ability and limited growth, malnutrition is a major driver driving the worldwide parenteral nutrition market. Another factor driving expansion in the global parenteral nutrition market is the increased prevalence and incidence rate of chronic diseases around the world. According to UNICEF, inadequate nutrition in the first 1,000 days of an infant's life can contribute to cognitive impairment and stunted growth. Vitamins, minerals, amino acids, carbohydrates, and fats must all be present in an infant's diet. Parenteral nutrition can be used to deliver these essential nutrients, which is expected to drive market expansion.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on ‘Global Parenteral Nutrition Market, By Nutrition Type (Single Dose Amino Acid Solution, Carbohydrates, Parenteral Lipid Emulsion, Trace Elements, and Vitamins & Minerals) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast Till 2029

Key Market Insights from the report:

The Global Parenteral Nutrition Market accounted for US$ 5.90 billion in 2020 and is estimated to be US$ 10.33 million by 2030 and is anticipated to register a CAGR of 5.8%. The Global Parenteral Nutrition Market is segmented based on the nutrition type and region.

By Nutrition Type, the market is segmented into Single Dose Amino Acid Solution, Carbohydrates, Parenteral Lipid Emulsion, Trace Elements, and Vitamins & Minerals.
By Region, the Global Parenteral Nutrition Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the global parenteral nutrition market.

Competitive Landscape:

The key players operating in the global Parenteral Nutrition Market includes Actavis, Inc., Aculife, Healthcare Private Ltd. , Baxter International, Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc., Grifols International S.A., Otsuka Pharmaceutical Factory, Inc., Sichuan Kelun Pharmaceutical Co. Ltd. and Vifor Pharma.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period